# Prokidney Corp.: filings

PROK · Nasdaq · CIK 1850270 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/prok.md) · [Financials](/companies/prok/financials.md) · [Filings](/companies/prok/filings.md) · [Insiders](/companies/prok/insiders.md)

## Reports and events: 114 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 125, 8-K 63, 3 26, DEFA14A 22, 10-Q 16, 424B3 15, 144 11, CORRESP 9, EFFECT 9, SC 13D/A 8, SC 13G/A 8, UPLOAD 7, 8-K/A 6, 10-K 5, POS AM 5, S-8 5, SC 13G 5, 424B5 4, ARS 4, S-8 POS 4, SC 13D 4, DEF 14A 3, S-1/A 3, SCHEDULE 13D/A 3, PRER14A 2, S-1 2, S-3 2, 10-K/A 1, 424B4 1, 4/A 1, 8-A12B 1, 8-K12B 1, 8-K12B/A 1, CERT 1, DEFM14A 1, DEL AM 1, DRS 1, PREM14A 1, S-1MEF 1, S-4 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 17:15 ET | [8-K](/filings/0001193125-26-438071.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-438071 |
| 2026-08-10 | 16:11 ET | [8-K](/filings/0001193125-26-342397.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-342397 |
| 2026-08-10 | 16:10 ET | [10-Q](/filings/0001193125-26-342373.md) | Quarterly report, period 2026-06-30 | 0001193125-26-342373 |
| 2026-05-29 | 16:02 ET | [8-K](/filings/0001193125-26-248210.md) | 5.07 Shareholder vote results | 0001193125-26-248210 |
| 2026-05-15 | 11:49 ET | [8-K](/filings/0001193125-26-225848.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-225848 |
| 2026-05-15 | 11:47 ET | [10-Q](/filings/0001193125-26-225841.md) | Quarterly report, period 2026-03-31 | 0001193125-26-225841 |
| 2026-04-30 | 16:24 ET | [SCHEDULE 13D/A](/filings/0001140361-26-018258.md) | Ownership report, active investor, amended | 0001140361-26-018258 |
| 2026-04-17 | 16:05 ET | [DEF 14A](/filings/0001140361-26-015362.md) | Proxy statement, period 2026-05-28 | 0001140361-26-015362 |
| 2026-03-18 | 16:03 ET | [8-K](/filings/0001193125-26-113893.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-113893 |
| 2026-03-18 | 16:01 ET | [10-K](/filings/0001193125-26-113881.md) | Annual report, period 2025-12-31 | 0001193125-26-113881 |
| 2026-02-02 | 16:04 ET | [8-K](/filings/0001193125-26-033594.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-033594 |
| 2026-01-12 | 07:54 ET | [8-K](/filings/0001193125-26-009807.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-009807 |
| 2025-11-10 | 16:20 ET | [8-K](/filings/0001193125-25-274314.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-274314 |
| 2025-11-10 | 16:18 ET | [10-Q](/filings/0001193125-25-274303.md) | Quarterly report, period 2025-09-30 | 0001193125-25-274303 |
| 2025-10-17 | 16:32 ET | [8-K](/filings/0001193125-25-242565.md) | 1.01 Entry into a material agreement | 0001193125-25-242565 |
| 2025-08-12 | 16:20 ET | [8-K](/filings/0000950170-25-107357.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-107357 |
| 2025-08-12 | 16:18 ET | [10-Q](/filings/0000950170-25-107352.md) | Quarterly report, period 2025-06-30 | 0000950170-25-107352 |
| 2025-07-15 | 07:43 ET | [8-K](/filings/0001193125-25-159041.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-159041 |
| 2025-07-14 | 17:12 ET | [8-K](/filings/0001193125-25-158806.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-158806 |
| 2025-07-08 | 07:03 ET | [8-K](/filings/0000950170-25-094445.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-094445 |
| 2025-07-01 | 13:10 ET | [8-K](/filings/0001140361-25-024348.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-024348 |
| 2025-06-05 | 16:18 ET | [SCHEDULE 13D/A](/filings/0001315863-25-000444.md) | Ownership report, active investor, amended | 0001315863-25-000444 |
| 2025-05-30 | 16:02 ET | [8-K](/filings/0000950170-25-079685.md) | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure | 0000950170-25-079685 |
| 2025-05-12 | 16:18 ET | [8-K](/filings/0000950170-25-069254.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-069254 |
| 2025-05-12 | 16:17 ET | [10-Q](/filings/0000950170-25-069251.md) | Quarterly report, period 2025-03-31 | 0000950170-25-069251 |
| 2025-03-17 | 17:22 ET | [10-K](/filings/0000950170-25-040483.md) | Annual report, period 2024-12-31 | 0000950170-25-040483 |
| 2025-03-17 | 16:50 ET | [8-K](/filings/0000950170-25-040417.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-040417 |
| 2025-02-06 | 16:40 ET | [SCHEDULE 13D/A](/filings/0001011438-25-000080.md) | Ownership report, active investor, amended | 0001011438-25-000080 |
| 2025-01-21 | 16:05 ET | [8-K](/filings/0000950170-25-007217.md) | 1.01 Entry into a material agreement | 0000950170-25-007217 |
| 2024-11-22 | 16:09 ET | [8-K](/filings/0000950170-24-130207.md) | 1.01 Entry into a material agreement | 0000950170-24-130207 |
| 2024-11-12 | 16:02 ET | [10-Q](/filings/0000950170-24-125312.md) | Quarterly report, period 2024-09-30 | 0000950170-24-125312 |
| 2024-11-12 | 07:35 ET | [8-K](/filings/0000950170-24-124585.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-124585 |
| 2024-09-03 | 07:33 ET | [8-K](/filings/0000950170-24-102554.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-102554 |
| 2024-08-09 | 16:03 ET | [10-Q](/filings/0000950170-24-094732.md) | Quarterly report, period 2024-06-30 | 0000950170-24-094732 |
| 2024-08-09 | 07:10 ET | [8-K](/filings/0000950170-24-094341.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-094341 |
| 2024-06-25 | 16:08 ET | [SC 13D/A](/filings/0001140361-24-031299.md) | Ownership report, active investor, amended | 0001140361-24-031299 |
| 2024-06-14 | 16:01 ET | [SC 13D/A](/filings/0001315863-24-000510.md) | Ownership report, active investor, amended | 0001315863-24-000510 |
| 2024-06-13 | 09:06 ET | [8-K](/filings/0001193125-24-160339.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-160339 |
| 2024-06-10 | 08:00 ET | [8-K](/filings/0001193125-24-157913.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-157913 |
| 2024-05-31 | 16:19 ET | [8-K](/filings/0000950170-24-067341.md) | 5.07 Shareholder vote results | 0000950170-24-067341 |
| 2024-05-29 | 07:04 ET | [8-K](/filings/0001140361-24-027808.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-24-027808 |
| 2024-05-10 | 16:03 ET | [10-Q](/filings/0000950170-24-057785.md) | Quarterly report, period 2024-03-31 | 0000950170-24-057785 |
| 2024-05-10 | 07:05 ET | [8-K](/filings/0000950170-24-057443.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-057443 |
| 2024-04-26 | 16:28 ET | [DEF 14A](/filings/0001140361-24-022484.md) | Proxy statement, period 2024-05-30 | 0001140361-24-022484 |
| 2024-03-25 | 16:07 ET | [8-K](/filings/0000950170-24-035914.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-035914 |
| 2024-03-22 | 20:00 ET | [8-K](/filings/0000950170-24-034961.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-034961 |
| 2024-03-22 | 19:36 ET | [10-K](/filings/0000950170-24-034946.md) | Annual report, period 2023-12-31 | 0000950170-24-034946 |
| 2024-03-18 | 16:09 ET | [8-K/A](/filings/0000950170-24-032827.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-032827 |
| 2024-03-18 | 16:05 ET | [8-K/A](/filings/0000950170-24-032821.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-032821 |
| 2024-02-12 | 16:05 ET | [8-K](/filings/0000950170-24-013823.md) | 5.02 Departure or appointment of officers or directors | 0000950170-24-013823 |

Page 1 of 3. [Older](/companies/prok/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 16:09 ET. No prices; not investment advice.